LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads) on and off LinkedIn. Learn more in our Cookie Policy.
Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings.
This range is provided by Lexeo Therapeutics. Your actual pay will be based on your skills and experience — talk with your recruiter to learn more.
Base pay range
$275,000.00/yr - $348,000.00/yr
Role Summary
Lexeo is seeking an experienced and motivated clinical development leader to advance late-stage development programs as a key member of our development team. This individual will report to the Vice President, Clinical Development and will provide strategic and hands-on leadership across clinical strategy, study execution, and cross-functional integration to deliver high-quality evidence to support regulatory interactions and submissions (e.g., BLA). This role requires strong scientific and operational judgment and the ability to build effective partnerships with internal stakeholders and external collaborators.
Primary Responsibilities
Provide clinical development leadership for assigned programs, including late-stage (Phase 2/3 and/or registrational) studies in rare disease and gene therapy
Partner with Regulatory, CMC, Quality, Biometrics, Medical Writing, and Clinical Operations to shape an integrated development plan aligned with program objectives and BLA strategy
Lead clinical strategy and oversight of protocol development, endpoint selection, eligibility criteria, safety monitoring approach, and clinical rationale to support health authority interactions
Serve as a clinical leader for investigator and external expert engagement, including KOL interactions, advisory boards (as applicable), and site relationships to support enrollment and high-quality study conduct
Drive cross-functional issue resolution and risk management for study execution; ensure decisions are documented and aligned with quality standards and inspection readiness
Contribute to BLA readiness by ensuring clinical deliverables and timelines are aligned across functions (e.g., CSR strategy, data review readiness, and clinical modules inputs)
Lead and/or mentor team members through matrix leadership; support a culture of accountability, collaboration, and scientific rigor.
Required Skills And Qualifications
PhD, PharmD, or MD with 5 - 6 years of progressive experience in the biotechnology or pharmaceutical industry within clinical development and late-stage trial delivery
Proven experience leading late-stage (Phase 2/3 and/or registrational) development for rare disease programs
Demonstrated experience supporting regulatory submission readiness, including BLA filing activities (e.g., clinical deliverables coordination, inspection readiness support, and cross-functional alignment)
Thorough knowledge of development program management from IND through NDA/BLA, including audit/inspection readiness
Experience partnering with Clinical Operations and CROs/vendors to deliver high-quality data and documentation, including milestone management, budget awareness, and reporting/CSR support
Advanced working knowledge of relevant guidelines and regulations (including ICH, GCP, and FDA requirements)
Ability to operate effectively in a fast-paced environment with shifting priorities and timelines
Excellent communication skills and demonstrated ability to influence across multiple functions and levels, internally and externally.
About Lexep Lexeo Therapeutics is a clinical-stage genetic medicine company headquartered in New York City, pioneering cardiac genetic medicine candidates to treat the root causes of inherited cardiovascular diseases. Our lead program, LX2006, targets cardiomyopathy associated with Friedreich’s Ataxia and anchors a broader pipeline addressing genetically defined conditions such as hypertrophic and arrhythmogenic cardiomyopathies. Backed by a strong financial foundation, Lexeo is positioned to translate groundbreaking science into durable clinical impact.
Our work culture is a hybrid model with 2 days/week in the New York City office and 3 days working from home.
Lexeo Therapeutics is an EEO employer committed to an exciting, diverse, and enriching work environment. We may use artificial intelligence (AI) tools to support parts of the hiring process, such as reviewing applications, analyzing resumes, or assessing responses. These tools assist our recruitment team but do not replace human judgment. Final hiring decisions are ultimately made by humans. If you would like more information about how your data is processed, please contact us.
Seniority level
Not Applicable
Employment type
Full-time
Job function
Research, Analyst, and Information Technology
Industries
Business Consulting and Services, IT Services and IT Consulting, and Professional Training and Coaching
Referrals increase your chances of interviewing at Lexeo Therapeutics by 2x